Literature DB >> 30600887

Total Synthesis and Anticancer Activity of (+)-Hypercalin C and Congeners.

Yongfeng Tao1, Keighley Reisenauer2, Joseph H Taube2, Daniel Romo1.   

Abstract

The hypercalins are dearomatized acylphloroglucinols with a pendant complex cyclopentane ring that exhibit activity against several cancer cell lines. We report the first total synthesis of (+)-hypercalin C employing a convergent strategy that enabled the dissection of the essential structural features required for the observed anticancer activity. A strategic disconnection involving an unusual C sp 3 -C sp 2 Suzuki-Miyaura coupling with an α-bromo enolether also revealed an unexpected C-H activation. This strategy targeted designed analogues along the synthetic route to address particular biological questions. These results support the hypothesis that hypercalinC may act as a proton shuttle with the dearomatized acylphloroglucinol moiety being essential for this activity.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  C−H insertion; Suzuki-Miyaura coupling; chiral pool; protonophore; β-lactone

Year:  2019        PMID: 30600887      PMCID: PMC6438696          DOI: 10.1002/anie.201812909

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  26 in total

1.  Studies toward the total synthesis of garsubellin A: a concise synthesis of the 18-epi-tricyclic core.

Authors:  Hiroyuki Usuda; Motomu Kanai; Masakatsu Shibasaki
Journal:  Org Lett       Date:  2002-03-07       Impact factor: 6.005

2.  Diverse pathways for the palladium(II)-mediated oxidation of olefins by tert-butylhydroperoxide.

Authors:  Jin-Quan Yu; E J Corey
Journal:  Org Lett       Date:  2002-08-08       Impact factor: 6.005

3.  Differentiation of nonconventional "carbanions"-the total synthesis of nemorosone and clusianone.

Authors:  Chihiro Tsukano; Dionicio R Siegel; Samuel J Danishefsky
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

4.  Catalysts for Suzuki-Miyaura coupling processes: scope and studies of the effect of ligand structure.

Authors:  Timothy E Barder; Shawn D Walker; Joseph R Martinelli; Stephen L Buchwald
Journal:  J Am Chem Soc       Date:  2005-04-06       Impact factor: 15.419

5.  Total synthesis of (+/-)-garsubellin A.

Authors:  Akiyoshi Kuramochi; Hiroyuki Usuda; Kenzo Yamatsugu; Motomu Kanai; Masakatsu Shibasaki
Journal:  J Am Chem Soc       Date:  2005-10-19       Impact factor: 15.419

6.  Analogues of natural phloroglucinols as antagonists against both thromboxane A2 and leukotriene D4.

Authors:  M Tada; K Chiba; T Takakuwa; E Kojima
Journal:  J Med Chem       Date:  1992-04-03       Impact factor: 7.446

7.  Pd(OH)2/C-mediated selective oxidation of silyl enol ethers by tert-butylhydroperoxide, a useful method for the conversion of ketones to alpha,beta-enones or beta-silyloxy-alpha,beta-enones.

Authors:  Jin-Quan Yu; Hai-Chen Wu; E J Corey
Journal:  Org Lett       Date:  2005-03-31       Impact factor: 6.005

8.  Dirhodium(II) caprolactamate: an exceptional catalyst for allylic oxidation.

Authors:  Arthur J Catino; Raymond E Forslund; Michael P Doyle
Journal:  J Am Chem Soc       Date:  2004-10-27       Impact factor: 15.419

9.  Palladium-catalyzed oxygenation of unactivated sp3 C-H bonds.

Authors:  Lopa V Desai; Kami L Hull; Melanie S Sanford
Journal:  J Am Chem Soc       Date:  2004-08-11       Impact factor: 15.419

10.  Optimal TBHP allylic oxidation of Delta5-steroids catalyzed by dirhodium caprolactamate.

Authors:  Hojae Choi; Michael P Doyle
Journal:  Org Lett       Date:  2007-11-21       Impact factor: 6.005

View more
  1 in total

1.  Oxodealkenylative Cleavage of Alkene C(sp3 )-C(sp2 ) Bonds: A Practical Method for Introducing Carbonyls into Chiral Pool Materials.

Authors:  Andrew J Smaligo; Jason Wu; Nikolas R Burton; Allison S Hacker; Aslam C Shaikh; Jason C Quintana; Ruoxi Wang; Changmin Xie; Ohyun Kwon
Journal:  Angew Chem Int Ed Engl       Date:  2019-12-02       Impact factor: 15.336

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.